Singapore's latest Covid spike may be peaking, but don't stop vaccinating, health minister says

Singapore's health minister has urged the public to continue receiving Covid vaccinations as cases in the city state remain high.

from Health and Science https://ift.tt/Gr4Y81w
https://ift.tt/o7crjGO
https://ift.tt/ImCwP0e

Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma

Wall Street turned its focus to a handful of newer treatments in different disease areas in 2023, including weight loss medications and a new Alzheimer's drug.

from Health and Science https://ift.tt/QapxhjB
https://ift.tt/zRncLXi
https://ift.tt/7q1t59c

SEC charges ex-CEO of medical device company with fraud, says some devices were 'just a piece of plastic'

The SEC on Tuesday charged former Stimwave Technologies CEO with allegedly defrauding investors out of $41 million.

from Health and Science https://ift.tt/5zRbQ8d
https://ift.tt/zRncLXi
https://ift.tt/7q1t59c

Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips

Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club's Monthly Meeting.

from Health and Science https://ift.tt/P3sKLba
https://ift.tt/zRncLXi
https://ift.tt/7q1t59c

The weight loss drug boom isn't over yet — here's what to expect in the year ahead

2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance coverage and unpleasant side effects. 

from Health and Science https://ift.tt/jnqBbNS
https://ift.tt/PqzFYG8
https://ift.tt/SopAUZn

Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook

The launch of Eli Lilly's weight-loss drug Zepbound is going swimmingly in the U.S., Jefferies said Friday.

from Health and Science https://ift.tt/WvIOKnT
https://ift.tt/P0osHyh
https://ift.tt/OY4MZuq

Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says

Those results build on midstage trial data Moderna and Merck released earlier this year, which examined the efficacy of the combination over a shorter period.

from Health and Science https://ift.tt/gRaJc4w
https://ift.tt/GcsXRDE
https://ift.tt/Oc4yDho

Vertex shares pop after nonopioid painkiller posts positive midstage trial results

The results support Vertex's hopes of developing a drug that can provide strong pain relief without the addictive potential of opioid medications.

from Health and Science https://ift.tt/oOwW6QH
https://ift.tt/OYkr8SG
https://ift.tt/j3cOMIp

Google is rolling out new AI models for health care. Here's how doctors are using them

Google announces MedLM, a new suite of health-care specific AI models.

from Health and Science https://ift.tt/nyMYvCf
https://ift.tt/OYkr8SG
https://ift.tt/j3cOMIp

Weight gain after stopping Eli Lilly's new obesity treatment should help, not hurt the stock

Data showing weight gain after stopping Eli Lilly's Zepbound was positive despite earlier selling pressure, Jim Cramer said Tuesday.

from Health and Science https://ift.tt/h5aXsOq
https://ift.tt/OYkr8SG
https://ift.tt/j3cOMIp

Patients regain weight after stopping Eli Lilly's Zepbound, study says

The data suggests that people have to stay on the weekly injection Zepbound if they want to maintain weight loss.

from Health and Science https://ift.tt/SarsKMC
https://ift.tt/PMnhSsk
https://ift.tt/lomp0sH

Flying solo without Cigna will keep Humana focused on 2 big priorities in the year ahead

Humana can now work to keep up its strong performance in Medicare Advantage and execute on a smooth CEO transition.

from Health and Science https://ift.tt/Ka86EVR
https://ift.tt/PMnhSsk
https://ift.tt/lomp0sH

Fraud in a bottle: How Big Pharma takes on criminals who make millions off counterfeit drugs

A CNBC investigation found criminal networks altering pill bottles of lifesaving drugs and then selling them back to pharmacies at large discounts.

from Health and Science https://ift.tt/Rs2ZjOg
https://ift.tt/PMnhSsk
https://ift.tt/lomp0sH

U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

Casgevy uses Nobel Prize-winning technology CRISPR to treat sickle cell disease, a blood disorder that affects about 100,000 Americans.

from Health and Science https://ift.tt/yVkNL86
https://ift.tt/dGxtNaz
https://ift.tt/eufVwyj

U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients

The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicine to use CRISPR.

from Health and Science https://ift.tt/bkIv6Of
https://ift.tt/PGF1R6K
https://ift.tt/60Ruvdw

Biden administration asserts power to seize drug patents in move to slash high prices

The Biden administration unveiled a new framework outlining the factors federal agencies should consider in determining whether to use march-in rights.

from Health and Science https://ift.tt/wnzvcAj
https://ift.tt/PGF1R6K
https://ift.tt/60Ruvdw

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.

from Health and Science https://ift.tt/xpPEcNM
https://ift.tt/PGF1R6K
https://ift.tt/60Ruvdw

Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages

Eli Lilly's drug serves as an alternative to rival obesity drugs such as Wegovy that are still facing supply issues. 

from Health and Science https://ift.tt/PyrtVbw
https://ift.tt/jLKVPBg
https://ift.tt/fNS0Q8X

CVS to change how it prices prescription drugs with new pharmacy reimbursement model

CVS's new effort aims to do away with a complex model that typically determines how much pharmacies get reimbursed and how much patients pay for medications. 

from Health and Science https://ift.tt/H0zZ4vC
https://ift.tt/jLKVPBg
https://ift.tt/fNS0Q8X

Reproductive startup launches test to identify an embryo's genetic defects before an IVF pregnancy begins

Orchid announces world's first whole genome sequencing report for embryos.

from Health and Science https://ift.tt/G8ybsiJ
https://ift.tt/zLGQWu5
https://ift.tt/zKFdn9c

Free ChatGPT may incorrectly answer drug questions, study says

The study shows that patients and health-care workers should be cautious about relying on OpenAI's viral chatbot for drug information, the lead author said.

from Health and Science https://ift.tt/8u2lkb4
https://ift.tt/zLGQWu5
https://ift.tt/zKFdn9c

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030

Roche is to acquire anti obesity drug developer Carmot Therapeutics, becoming the latest pharma company to enter the global weight-loss drugs market.

from Health and Science https://ift.tt/8an1PjM
https://ift.tt/zLGQWu5
https://ift.tt/zKFdn9c

Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops

Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades. 

from Health and Science https://ift.tt/MjBshcD
https://ift.tt/ZbEtiMY
https://ift.tt/nLk6SZX

Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly

Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that's good news for Club holding Eli Lilly (LLY).

from Health and Science https://ift.tt/zf3A4Xm
https://ift.tt/ZbEtiMY
https://ift.tt/nLk6SZX

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in the first half of 2024.

from Health and Science https://ift.tt/Mj21DpK
https://ift.tt/Aac3zd5
https://ift.tt/937yHq0